Results 171 to 180 of about 37,162 (308)

Use of second-generation antipsychotics in autism spectrum disorder: a systematic review and meta-analysis protocol. [PDF]

BMJ Open, 2023
Lopes LPN, de Oliveira JC, Bergamaschi CC, Fulone I, Lima EDC, Abe FC, Mazzei LG, Figueiró MF, Lopes LC.   +8 more
europepmc   +1 more source

Sleep Macrostructure, Cyclic Alternating Pattern and CSF Cytokines in De Novo Relapsing–Remitting Multiple Sclerosis: A Controlled Polysomnographic Study

Journal of Sleep Research, EarlyView.
ABSTRACT Multiple sclerosis is frequently associated with sleep disorders. This study aimed to evaluate subjective and objective sleep parameters in de novo relapsing–remitting multiple sclerosis patients compared to healthy controls and to explore correlations with cerebrospinal fluid cytokines.
A. Romigi, M. Stampanoni Bassi, M. Caccamo, L. Gilio, F. Ceriello, A. Finardi, G. Vitrani, I. Rosenzweig, R. Furlan, F. Buttari, D. Centonze   +10 more
wiley   +1 more source

Weight change from incretin-based weight loss medications across categories of second-generation antipsychotics. [PDF]

Int J Obes (Lond)
Varghese JS, Goldsmith DR, Cotes RO, Ravikumar V, Ali MK, Pasquel FJ.   +5 more
europepmc   +1 more source

Comment on "An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use". [PDF]

Ment Health Clin, 2023
Still D, Do K, Thompson P, Brackins T, McGrory J.   +4 more
europepmc   +1 more source

Investigation of the “Not Better Explained” Diagnosis Criteria in Sleep Disorder Classifications: A Systematic Content Analysis and Critical Review

Journal of Sleep Research, EarlyView.
The “Not Better Explained” (NBE) criterion plays a key role in preventing diagnostic misclassification by structuring causal reasoning in sleep medicine. This systematic content analysis compares the use, wording, and excluded conditions of NBE criteria across the ICSD‐3‐TR and DSM‐5‐TR for ten major sleep disorders.
Jean‐Arthur Micoulaud‐Franchi, Vincent P. Martin, Julien Coelho, Régis Lopez, Pierre‐Alexis Geoffroy, Laure Peter‐Derex, Isabelle Lambert, Charles M. Morin, Clélia Quiles, Christophe Gauld   +9 more
wiley   +1 more source

Epigenetics in pharmacogenes encoding metabolizing enzymes of second-generation antipsychotics used in schizophrenia and its clinical implications. [PDF]

Front Pharmacol
Alvarado AT, Zavaleta AI, Li-Amenero C, Bendezú MR, Garcia JA, Chávez H, Palomino-Jhong JJ, Surco-Laos F, Laos-Anchante D, Melgar-Merino EJ, Bolarte-Arteaga M, Tasayco-Yataco N, Pariona-Llanos R.   +12 more
europepmc   +1 more source

Onset of Action of Selected Second-Generation Antipsychotics (Pines)-A Systematic Review and Meta-Analyses. [PDF]

Biomedicines, 2022
Meyer R, Skov K, Dhillon IK, Olsson E, Graudal NA, Baandrup L, Jürgens G.   +6 more
europepmc   +1 more source

A Review of the Effects of Maternal and Paternal Obesity on Neurodevelopmental Disorders and Related Neurobiology in Rodent and Human Offspring

Obesity Reviews, EarlyView.
ABSTRACT Obesity is one of the most prevalent health problems worldwide, and global obesity rates continue to rise. Consequently, rates of obesity in expecting mothers and fathers have also increased. The Developmental Origins of Health and Disease (DOHaD) hypothesis postulates that early‐life exposure to adverse environmental conditions contributes to
Hannah Chadwick, Victorio Bambini Junior, Neil Dawson, Cheryl A. Hawkes   +3 more
wiley   +1 more source

Genome-wide associations with metabolic syndrome among UK Biobank participants reporting use of second-generation antipsychotics. [PDF]

Pharmacotherapy
Rouby NE, Owusu-Obeng A, Preuss M, Lee S, Shi M, Lape M, Martin LJ, Namjou-Khales B, Kottyan LC, Van Driest SL, Mosley JD, DelBello MP.   +11 more
europepmc   +1 more source

Efficacy and tolerance of second-generation antipsychotics in anorexia nervosa: A systematic scoping review. [PDF]

PLoS One, 2023
Thorey S, Blanchet C, Guessoum SB, Moro MR, Ludot M, Carretier E.   +5 more
europepmc   +1 more source